Categories
- ACTUARIAL DATA SCIENCE
- AFIR / ERM / RISK
- ASTIN / NON-LIFE
- BANKING / FINANCE
- DIVERSITY & INCLUSION
- EDUCATION
- HEALTH
- IACA / CONSULTING
- LIFE
- PENSIONS
- PROFESSIONALISM
- Thought Leadership
- MISC
Liquid biopsy technology is increasingly used in many areas of clinical medicine with its greatest success currently in the field of oncology. This informative panel discussion examines both the positive and challenging ways this technology impacts the insurance industry.
To learn more about this topic, please send your request to the RGA speakers Daniel Zimmerman, Andrew Gaskell and Heather M. Lund.
0 Comments
There are no comments yet. Add a comment.